GlassScriptPhysician profile
Victor Keith Jiminez
NPI 1013969039
$8,891.88
in general payments reported to CMS, 2019-2025
48 companies · $1,797 in 2025
The $1,797 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $866 · 2020: $619 · 2021: $778 · 2022: $1,028 · 2023: $2,108 · 2024: $1,696 · 2025: $1,797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,917 · Travel and Lodging: $527 · Education: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,916.60 |
| Travel and Lodging | $527.05 |
| Education | $157.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,647.84 | 2019-2024 | Da Vinci Surgical System |
| Astellas Pharma US INC | $1,426.62 | 2019-2025 | Myrbetriq, Xtandi |
| Sumitomo Pharma America, INC. | $750.15 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $518.00 | 2021-2025 | |
| Allergan, INC. | $365.00 | 2019-2022 | |
| Coloplast Corp | $317.48 | 2019-2025 | |
| Procept Biorobotics Corporation | $302.09 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Antares Pharma, INC. | $262.00 | 2019-2025 | Xyosted |
| Janssen Biotech, INC. | $233.84 | 2019-2025 | Erleada |
| Ferring Pharmaceuticals INC. | $232.50 | 2024-2025 | Adstiladrin |
| Pfizer INC. | $214.28 | 2019-2025 | |
| Verity Pharmaceuticals INC. | $165.58 | 2023-2024 | Trelstar |
| Tolmar, INC. | $160.05 | 2023-2025 | Eligard, Jatenzo |
| Boston Scientific Corporation | $152.80 | 2019-2024 | Rezum Generator, Ams 700 Cxr Rte Kit |
| Urogen Pharma, INC. | $148.69 | 2021-2025 | Jelmyto |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $138.45 | 2021-2025 | Interstim |
| Rochester Medical Corporation | $138.03 | 2019-2021 | |
| Urovant Sciences INC | $136.52 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $134.18 | 2021-2024 | Prolaris |
| Endo Pharmaceuticals INC. | $132.33 | 2019-2024 | Xiaflex |
| Endo USA, INC. | $120.02 | 2024-2025 | Xiaflex |
| Immunitybio, INC. | $114.01 | 2024-2025 | |
| Abc Home Medical Supply, INC. | $92.12 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $87.80 | 2021-2024 | |
| Tolmar Pharmaceuticals, INC. | $80.48 | 2019-2022 | |
| Olympus America INC. | $74.61 | 2023-2025 | Itind System, Olympus, Bovie |
| Axonics, INC. | $74.50 | 2022-2024 | Axonics, Bulkamid |
| Travere Therapeutics, INC. | $60.14 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $57.47 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Accord Healthcare, INC. | $55.28 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $50.43 | 2021-2025 | Pylarify |
| Blue Earth Diagnostics | $44.46 | 2019-2021 | |
| Halozyme INC | $41.25 | 2023 | |
| Clarus Therapeutics INC. | $35.55 | 2021 | |
| Mission Pharmacal Company | $34.88 | 2022 | |
| Dendreon Pharmaceuticals LLC | $34.77 | 2021 | |
| Edap Technomed INC | $33.00 | 2024 | |
| Myovant Sciences INC. | $28.06 | 2022 | |
| Janssen Scientific Affairs, LLC | $28.05 | 2019 | |
| Healthtronics Stone Solutions, LLC | $23.99 | 2025 | Dornier Medtech, Dornier Medtech, Cvac Aspiration System |
| Conmed Corporation | $22.54 | 2023 | Airseal |
| Calyxo, INC. | $21.96 | 2024 | Cvac Aspiration System |
| Amgen INC. | $19.95 | 2020 | |
| Abbott Laboratories | $18.29 | 2022 | |
| Cycle Pharmaceuticals INC | $16.14 | 2024 | Tiopronin |
| Novo Nordisk INC | $15.90 | 2024 | |
| Zyla Life Sciences, INC. | $15.22 | 2019 | |
| Eisai INC. | $14.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Jiminez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.